MEI Pharma, Inc. Stock Agreements
14 Contracts & Agreements
- Amended and Restated 2008 Stock Omnibus Equity Compensation Plan (December 2023) (Filed With SEC on May 9, 2024)
- Description of MEI Common Stock (Filed With SEC on September 26, 2023)
- Amended and Restated 2008 Stock Omnibus Equity Compensation Plan (Filed With SEC on December 17, 2020)
- Description of Capital Stock of MEI Pharma, Inc (Filed With SEC on September 9, 2020)
- Amended and Restated 2008 Stock Omnibus Equity Compensation Plan (Filed With SEC on November 30, 2018)
- MEI PHARMA, INC. AMENDED AND RESTATED 2008 STOCK OMNIBUS EQUITY COMPENSATION PLAN (Filed With SEC on December 2, 2016)
- MEI PHARMA, INC. AMENDED AND RESTATED 2008 STOCK OMNIBUS EQUITY COMPENSATION PLAN (Filed With SEC on December 4, 2015)
- MEI PHARMA, INC. AMENDED AND RESTATED 2008 STOCK OMNIBUS EQUITY COMPENSATION PLAN (Filed With SEC on December 4, 2014)
- MEI PHARMA, INC. AMENDED AND RESTATED 2008 STOCK OMNIBUS EQUITY COMPENSATION PLAN (Filed With SEC on March 29, 2013)
- MARSHALL EDWARDS, INC. AMENDED AND RESTATED 2008 STOCK OMNIBUS EQUITY COMPENSATION PLAN (Filed With SEC on December 5, 2011)
- MARSHALL EDWARDS, INC. NONQUALIFIED STOCK OPTION GRANT (Filed With SEC on June 2, 2011)
- STOCK PURCHASE AGREEMENT (Filed With SEC on March 18, 2011)
- MARSHALL EDWARDS, INC. Common Stock (par value $0.00000002 per share) At Market Issuance Sales Agreement (Filed With SEC on February 7, 2011)
- SPECIMEN COMMON STOCK CERTIFICATE (Filed With SEC on October 31, 2003)
